CADOUX LIMITED — Director's Dealing 2005

Nov 28, 2005

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

	Name of entity Solbec Pharmaceuticals Ltd
IABN	85 061 289 218

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Graeme Bruce Howie
Date of last notice	N/A

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the $trust$

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise. to the relevant interest.	$\mathbf{r}$
Date of change	28 November 2005
No. of securities held prior to change	N 1
Class	Ordinary fully paid
Number acquired	100,000
Number disposed	$\omega$
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	\$9,135.00
No. of securities held after change
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	On market trade

⁺ See chapter 19 for defined terms.

Detail of contract
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation to which the interest
has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, estimated provide details and an
valuation
Interest after change

Part 2 - Change of director's interests in contracts

⁺ See chapter 19 for defined terms.